LCGC
CRSP icon

Legacy Capital Group California’s CRISPR Therapeutics CRSP Stock Holding History

Legacy Capital Group California’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,318
Closed -$840K – 317
2024
Q1 		$840K Sell
12,318
-329
-3% -$22.4K 0.31% 102
2023
Q4 		$792K Buy
+12,647
New +$792K 0.31% 95